Abstract

See related article, pages 572–580 Atherosclerosis is, in large part, an inflammatory process. White blood cells of different lineages are essential components of the atherosclerotic plaque. More important than their numbers, white blood cells influence the structure of an atherosclerotic plaque, and the function of the vessel in which the plaque is present, by secreting a host of agents that affect resident vascular cells.1 Macrophages, derived from circulating monocytes, are one class of white blood cells that, as part of the atherosclerotic plaque, play a critical part in the progression of the plaque, and in compromising its structural integrity.1 Long before an atherosclerotic plaque is clinically detectable, one of the earliest steps in its genesis is the adhesion of circulating monocytes to the endothelium, and subsequent transmigration into the vessel wall. Because it is well-recognized that these very early stages are critical to plaque development, a great deal of energy has been devoted to trying to understand the mechanisms underpinning them. The work by Hedrick and colleagues in this issue of Circulation Research 2 adds to this understanding. This work examines the part of a G protein–coupled receptor, G2A, in modulating the interaction between monocytes and the vascular endothelium. Using mice that are deficient …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call